IVVD SEC Filing News — Invivyd, Inc.

Latest SEC filings for Invivyd, Inc. (IVVD) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-09-29.

Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase …
Sector: Healthcare Industry: Biotechnology Market Cap: $185.1M
12
Total Filings
0
Bullish Classifications
5
Bearish Classifications
7
Insider Transactions
2
Material Events (8-K)
0
Periodic Reports
Rule-based classifications for IVVD currently lean bearish. Of the 12 filing records displayed, 5 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
IVVD Filing Activity Snapshot 2026-08-17 — 2026-09-29
Insider Transactions (Form 4)
0 buys vs 5 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$52.8K
Andersen Jill (Chief Legal Officer, Secretary) · 2026-08-18
67,962 shares · Form 4
Form 144 Notices
3
Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 7 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 7 filings in this group are Form 4s for Invivyd, Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 7 insider filings shown, the breakdown is 5 open-market sale and 2 compensation award. 5 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Open-market sale ×5
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Compensation award ×2
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Form 4 Compensation award Tax / Compensation Filing 2026-09-02

IVVD insider Form 4 filed for equity award, exercise, or tax withholding

Sheffield Ian (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Stock Option (Right to Buy) 100,000 — —
Filing: Form 4 (Insider Transaction) Insider: Sheffield Ian (Director)
Form 4 Compensation award Tax / Compensation Filing 2026-09-01

IVVD insider Form 4 filed for equity award, exercise, or tax withholding

Elia Marc (Director, Chief Executive Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Stock Option (Right to Buy) 10,700,000 — —
Filing: Form 4 (Insider Transaction) Insider: Elia Marc (Director, Chief Executive Officer)
Form 4 Open-market sale Insider Selling 2026-08-18

IVVD insider Lee Timothy Edward (Chief Commercial Officer) sold 40,780 shares (~$31.7K)

Lee Timothy Edward, listed as Chief Commercial Officer at Invivyd, Inc., reported an open-market sale of 40,780 IVVD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 102,000 — —
S Open-market sale 22,355 $0.72 $16.1K
S Open-market sale 18,425 $0.84 $15.5K
M Option exercise derivative · Restricted Stock Units 102,000 — —
Filing: Form 4 (Insider Transaction) Insider: Lee Timothy Edward (Chief Commercial Officer) Shares: 40,780 Est. Value: $31.7K
Form 4 Open-market sale Insider Selling 2026-08-18

IVVD insider Green Julie (Chief Human Resources Officer) sold 40,780 shares (~$31.7K)

Green Julie, listed as Chief Human Resources Officer at Invivyd, Inc., reported an open-market sale of 40,780 IVVD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 102,000 — —
S Open-market sale 22,355 $0.72 $16.1K
S Open-market sale 18,425 $0.84 $15.5K
M Option exercise derivative · Restricted Stock Units 102,000 — —
Filing: Form 4 (Insider Transaction) Insider: Green Julie (Chief Human Resources Officer) Shares: 40,780 Est. Value: $31.7K
Form 4 Open-market sale Insider Selling 2026-08-18

IVVD insider Duke William E. (Chief Financial Officer) sold 40,780 shares (~$31.7K)

Duke William E., listed as Chief Financial Officer at Invivyd, Inc., reported an open-market sale of 40,780 IVVD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 102,000 — —
S Open-market sale 22,355 $0.72 $16.1K
S Open-market sale 18,425 $0.84 $15.5K
M Option exercise derivative · Restricted Stock Units 102,000 — —
Filing: Form 4 (Insider Transaction) Insider: Duke William E. (Chief Financial Officer) Shares: 40,780 Est. Value: $31.7K
Form 4 Open-market sale Insider Selling 2026-08-18

IVVD insider Andersen Jill (Chief Legal Officer, Secretary) sold 67,962 shares (~$52.8K)

Andersen Jill, listed as Chief Legal Officer, Secretary at Invivyd, Inc., reported an open-market sale of 67,962 IVVD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 170,000 — —
S Open-market sale 37,256 $0.72 $26.9K
S Open-market sale 30,706 $0.84 $25.9K
M Option exercise derivative · Restricted Stock Units 170,000 — —
Filing: Form 4 (Insider Transaction) Insider: Andersen Jill (Chief Legal Officer, Secretary) Shares: 67,962 Est. Value: $52.8K
Form 4 Open-market sale Insider Selling 2026-08-18

IVVD insider Allen Robert D. III (Chief Scientific Officer) sold 37,722 shares (~$29.3K)

Allen Robert D. III, listed as Chief Scientific Officer at Invivyd, Inc., reported an open-market sale of 37,722 IVVD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 102,000 — —
S Open-market sale 20,679 $0.72 $14.9K
S Open-market sale 17,043 $0.84 $14.4K
M Option exercise derivative · Restricted Stock Units 102,000 — —
Filing: Form 4 (Insider Transaction) Insider: Allen Robert D. III (Chief Scientific Officer) Shares: 37,722 Est. Value: $29.3K
Proposed Insider Sales 3 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Invivyd, Inc. has 3 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-08-17

IVVD Form 144 filed for proposed insider sale by Lee Timothy Edward (40,800 shares) ~$29.4K

Lee Timothy Edward filed a Form 144 with the SEC indicating intent to sell IVVD (Invivyd, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Lee Timothy Edward Shares: 40,800 Est. Value: $29.4K
Form 144 Proposed Insider Sale 2026-08-17

IVVD Form 144 filed for proposed insider sale by Green Julie (40,800 shares) ~$29.4K

Green Julie filed a Form 144 with the SEC indicating intent to sell IVVD (Invivyd, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Green Julie Shares: 40,800 Est. Value: $29.4K
Form 144 Proposed Insider Sale 2026-08-17

IVVD Form 144 filed for proposed insider sale by Duke William E. (40,800 shares) ~$29.4K

Duke William E. filed a Form 144 with the SEC indicating intent to sell IVVD (Invivyd, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Duke William E. Shares: 40,800 Est. Value: $29.4K
Material Events 2 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 2 in this period for Invivyd, Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-09-29

IVVD filed 8-K — material company event

Invivyd, Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-09-01

IVVD filed 8-K — material company event

Invivyd, Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)

How we classify Invivyd, Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on IVVD. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — IVVD SEC Filings

More Tools for IVVD

Want deeper IVVD analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the IVVD stock analysis page.

IVVD Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer